Valsartan

angiotensinogen ; Homo sapiens







131 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
101 10028951 Angiotensin II antagonism in clinical practice: experience with valsartan. 1999 1
102 10028952 Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophy. 1999 1
103 10232502 A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension. 1999 Apr 1
104 10358862 [Diovan efficacy and tolerance in mild and moderate hypertension]. 1999 1
105 10442512 Valsartan inhibits angiotensin II-stimulated proliferation of smooth muscle cells from human coronary artery. 1999 Jul 3
106 10449888 Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophy. 1999 2
107 10449890 Clinical advantage of valsartan. 1999 2
108 10463202 Treatment with the angiotensin II antagonist valsartan in patients with chronic renal failure and hypertension. 1999 1
109 10546920 Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay. 1999 Oct 1
110 10587770 Valsartan. Just a second-line antihypertensive drug. 1999 Nov 2
111 10588088 Angiotensin II receptor blockers: review of the binding characteristics. 1999 Nov 18 1
112 9551704 An interaction study with cimetidine and the new angiotensin II antagonist valsartan. 1998 Feb 1
113 9570479 Angiotensin II stimulation of the stress-activated protein kinases in renal mesangial cells is mediated by the angiotensin AT1 receptor subtype. 1998 Feb 19 3
114 9761285 Angiotensin II and insulin induce growth of ciliary artery smooth muscle: effects of AT1/AT2 antagonists. 1998 Oct 1
115 9808602 Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension. 1998 Nov 10 1
116 9848776 Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension. 1998 Dec 1
117 9853274 Effect of indomethacin on the renal response to angiotensin II receptor blockade in healthy subjects. 1998 Dec 1
118 15991938 Pharmacology of valsartan, an angiotensin II receptor antagonist. 1998 Nov 3
119 9024172 The effect of valsartan on the angiotensin II pressor response in healthy normotensive male subjects. 1997 Jan 9
120 9218922 Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide. 1997 2
121 9220209 Valsartan, a new angiotensin II antagonist: antihypertensive effects over 24 hours. 1997 May-Jun 1
122 9257084 Valsartan. A review of its pharmacology and therapeutic use in essential hypertension. 1997 Aug 2
123 9322828 Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril. 1997 Aug 1
124 9333102 Pharmacokinetics of valsartan in patients with liver disease. 1997 Sep 1
125 9342579 Pharmacokinetics and pharmacodynamic effects of the angiotensin II antagonist valsartan at steady state in healthy, normotensive subjects. 1997 2
126 9421693 Treatment of patients with essential hypertension and microalbuminuria. 1997 Dec 1
127 10234113 Valsartan, a new angiotensin II antagonist; blood pressure reduction in essential hypertension compared with an angiotensin converting enzyme inhibitor, enalapril. 1997 Aug 2
128 8841157 Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine. 1996 Sep 2
129 8986917 Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril. 1996 Sep 2
130 7867676 Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects. 1994 2
131 7980530 Characterization of contractile endothelin and angiotensin receptors in human resistance arteries: evidence for two endothelin and one angiotensin receptor. 1994 Oct 28 1